SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC TO-C - Written communication relating to an issuer or third party:
SEC Accession No. 0001193125-19-046203
Filing Date
2019-02-21
Accepted
2019-02-21 07:43:09
Documents
5

Document Format Files

Seq Description Document Type Size
1 8-K d689051d8k.htm SC TO-C 34354
2 EX-2.1 d689051dex21.htm EX-2.1 470441
3 EX-99.1 d689051dex991.htm EX-99.1 17387
4 GRAPHIC g689051g0221050225525.jpg GRAPHIC 3507
5 GRAPHIC g689051g0221050225665.jpg GRAPHIC 4418
  Complete submission text file 0001193125-19-046203.txt   535407
Mailing Address 601 GATEWAY BOULEVARD SUITE 250 SOUTH SAN FRANCISCO CA 94080
Business Address 1616 EASTLAKE AVENUE E. SUITE 310 SEATTLE WA 98102 (650) 392-8350
IMMUNE DESIGN CORP. (Filed by) CIK: 0001437786 (see all company filings)

IRS No.: 262007174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC TO-C
SIC: 2834 Pharmaceutical Preparations

Mailing Address 601 GATEWAY BOULEVARD SUITE 250 SOUTH SAN FRANCISCO CA 94080
Business Address 1616 EASTLAKE AVENUE E. SUITE 310 SEATTLE WA 98102 (650) 392-8350
IMMUNE DESIGN CORP. (Subject) CIK: 0001437786 (see all company filings)

IRS No.: 262007174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC TO-C | Act: 34 | File No.: 005-88256 | Film No.: 19620524
SIC: 2834 Pharmaceutical Preparations